2026 Compounding HIV Treatment and Prevention Agents 
Pharmacy Times
AUGUST 2, 2025
These technologies prevent the risk of both hypo- and hyperglycemic episodes, facilitating safer fasting. The guidance is updated every 5 years, with the most recent update published in May 2025. Monitoring technology is valuable to assess glycemic control and enable timely interventions in T1D patients.
Drug Topics
JUNE 25, 2025
1,2 “There is an extraordinary unmet need in obesity treatment, which is the ability for patients to stop GLP-1 drugs without regaining weight. 1 “These early Revita data are better than I expected and suggest the potential to prevent the weight regain we see in practice. 1 REFERENCES 1. Fractyl Health. News release. June 23, 2025.
Expert insights. Personalized for you.
Let's personalize your content